NCT01825707View on ClinicalTrials.gov

AME Study of [14C]-YH4808 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy
Interventions
DRUG

[14C]-YH4808 200 mg

\[14C\]-YH4808 200 mg (oral) on day1

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01825707 - AME Study of [14C]-YH4808 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter